Abstract

PurposeLong-gap esophageal atresia represents a significant challenge for pediatric surgeons and current surgical approaches are associated with significant morbidity. A tissue-engineered esophagus, comprising cells seeded onto a scaffold, represents a therapeutic alternative. In this study, we aimed to determine the optimal techniques for isolation and culture of mouse esophageal epithelial cells and to isolate CD34-positive esophageal epithelial stem cells from cadaveric mouse specimens.MethodsPrimary epithelial cells were isolated from mouse esophagi by enzymatic dissociation from the mucosal layer (Dispase, Trypsin/EDTA) using three different protocols. In protocol A, isolated mucosa was minced and incubated with trypsin once. In protocol B, intact mucosal sheets underwent two trypsin incubations yielding a single-cell suspension. In protocol C, intact mucosa explants were plated epithelial side down. Epithelial cells were cultured on collagen-coated wells.ResultsInitial findings showed that Protocol B gave the best results in terms of yield, viability, and least contamination with different cell types and microbes. Esophageal epithelial cells isolated using Protocol B were stained for CD34 and sorted using fluorescence-activated cell sorting (FACS). Of the total cells sorted, 8.3 % (2–11.3) [%median (range)] were CD34 positive.ConclusionsOur results demonstrate that mouse esophageal epithelial cells can be successfully isolated from fresh mouse esophagi using two consecutive trypsin incubations of intact mucosal sheets. Furthermore, the cells obtained using this method were successfully stained for CD34, a putative esophageal epithelial stem cell marker. Further research into the factors necessary for the successful proliferation of CD34 positive stem cell lines is needed to progress toward clinical application.

Highlights

  • Long-gap esophageal atresiaEsophageal atresia (EA) is a congenital malformation of the esophagus which presents after birth with a global incidence of between 1 in 2,500 and 1 in 5,000 live births [1, 2]

  • Esophageal epithelial cells isolated using Protocol B were stained for CD34 and sorted using fluorescence-activated cell sorting (FACS)

  • The cells obtained using this method were successfully stained for CD34, a putative esophageal epithelial stem cell marker

Read more

Summary

Introduction

Long-gap esophageal atresiaEsophageal atresia (EA) is a congenital malformation of the esophagus which presents after birth with a global incidence of between 1 in 2,500 and 1 in 5,000 live births [1, 2]. For 10 % of EA cases, simple surgical anastomosis is not possible due to the presence of insufficient length in the distal segment of esophagus These cases, where a TEF is not present, are known as long-gap EA and have required the development of new Pediatr Surg Int (2014) 30:1249–1256 surgical approaches to repair, including circular myotomy [4] or interposition with colonic, gastric, or jejunal segments [5]. The non-mutually exclusive serious complications of leakage, stricture, and/or gastro-esophageal reflux remain a concern and lead to a mortality rate of 5.2 % [6] Both EA and long-gap EA present significant challenges that are not fully addressed with current therapeutic options

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call